Michelson Medical Research Foundation, Inc. Portfolio

Auto-discovered active 13F filer.

SEC 13F CIK: 0001965304

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedHigh Turnover how tags are computed

Q1 2026 · 21 positions · Total reported value $98.50M · Top-10 concentration 73.4% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 25.0% · 3 new · 0 cut · 3 exited

Active Share (vs S&P 500): 99.6% · vs QQQ: 99.4% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -2.5% · vs SPY -4.7% · Prev Value $108.22M — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): +1.6% · vs SPY -0.6% · Latest Value $112.52M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q1 2026 13F filing, Michelson Medical Research Foundation, Inc. disclosed 21 equity positions with a combined reported value of $98.50M. The filing implies a focused portfolio: its ten largest positions account for 73.4% of reported value. HoldingsHub classifies the profile as Small / Focused / High Turnover.

The largest disclosed positions as of Q1 2026 were MTN ($11.04M), IVE ($10.96M), VEA ($10.13M). By sector, the heaviest allocations are Consumer Discretionary 22.1%, Health Care 8.2%. Versus the prior quarter, allocation shifted toward Consumer Discretionary (+7.5pp), Other (+2.7pp) and away from Health Care (-1.7pp), Industrials (-1.9pp).

Versus the prior quarter, Michelson Medical Research Foundation, Inc. opened 3 new positions, trimmed 0 and fully exited 3, a turnover rate of 25.0% of positions. The portfolio's overlap with the prior quarter was 78% of names.

The largest new positions opened in Q1 2026 were CNNE ($5.46M), BATRK ($1.93M), OCSL ($1.92M).

Of the 3 positions fully exited versus the prior quarter, the largest were DBRG ($9.35M), RGR ($1.88M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q1 2026)

  • CNNE CANNAE HLDGS INC · $5.46M
  • BATRK ATLANTA BRAVES HLDGS INC · $1.93M
  • OCSL OAKTREE SPECIALTY LENDING · $1.92M

Fully Exited (vs previous quarter)

  • DBRG DigitalBridge Group Inc · prev qtr: $9.35M
  • RGR STURM RUGER & CO INC · prev qtr: $1.88M

Insider Transactions (Form 4)

Latest Michelson Medical Research Foundation, Inc. buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Michelson Medical Research Foundation, Inc. is an SEC-registered 13F filer. As of Q2 2026 it reported 21 US equity positions with a combined value of $108.22M. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Portfolio Structure

  • 21 positions · $108.22M reported value (Q2 2026)
  • Top 10 holdings = 72.1% of reported value
  • Largest position: IVE (ISHARES TR) at 10.9%
  • Average position size: $5.15M

Sector Tilt

  • Consumer Discretionary 20.8%
  • Financials 9.8%
  • Real Estate 4.3%
  • (classified holdings cover 36% of value)

Quarterly Activity

  • Q2 2026: 2 new, 2 exited
  • 19 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Energy 2.1%
Financials 2.0%
Other 61.5%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 86.00K $11.04M 11.20%
11.20%
Hold
2 51.91K $10.96M 11.13%
11.13%
Hold
3 158.16K $10.13M 10.29%
10.29%
Hold
4 30.00K $8.12M 8.24%
8.24%
Hold
5 127.63K $6.90M 7.00%
7.00%
Hold
6 35.09K $5.93M 6.02%
6.02%
Hold
7 35.38K $5.65M 5.73%
5.73%
Hold
8 480.60K $5.46M 5.55%
5.55%
New
9 63.51K $4.14M 4.20%
4.20%
Hold
10 297.48K $4.02M 4.09%
4.09%
Hold
11 200.00K $3.36M 3.42%
3.42%
Hold
12 41.85K $3.15M 3.20%
3.20%
Hold
13 81.30K $3.12M 3.17%
3.17%
Hold
14 11.01K $2.88M 2.93%
2.93%
Hold
15 20.16K $2.48M 2.52%
2.52%
Hold
16 156.17K $2.11M 2.14%
2.14%
Hold
17 27.43K $1.95M 1.98%
1.98%
Hold
18 45.13K $1.93M 1.96%
1.96%
New
19 170.10K $1.92M 1.95%
1.95%
New
20 20.10K $1.70M 1.72%
1.72%
Hold
21 16.75K $1.56M 1.58%
1.58%
Hold

FAQ

What did Michelson Medical Research Foundation, Inc. buy in 2026-Q1?

In its 2026-Q1 13F filing, Michelson Medical Research Foundation, Inc. reported 21 equity positions worth $98.50M in aggregate; its largest disclosed positions were MTN ($11.04M), IVE ($10.96M), VEA ($10.13M).

How large is Michelson Medical Research Foundation, Inc.'s portfolio?

Michelson Medical Research Foundation, Inc. reported $98.50M of long equity holdings across 21 positions as of 2026-Q1. Top-10 holdings account for 73.4% of reported value.

What is Michelson Medical Research Foundation, Inc.'s investment style?

HoldingsHub classifies the portfolio as Small / Focused / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/michelson-medical-research-foundation/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →